Oncocyte Shares Fall On Posting Wider Than Expected Q2 Loss
Oncocyte Corporation’s (NASDAQ:OCX) Q2 revenues were $2.03 million, compared to $143,000 in Q2 FY20 and beating consensus of $1.57 million.…
48 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) gained 82% to $25.19. The company, last month, priced its IPO at $11 per share.
OncoCyte Corporation Common Stock Q2 EPS $(0.12) Misses $(0.10) Estimate, Sales $2.03M Beat $1.57M Estimate
OncoCyte Corporation Common Stock (AMEX:OCX) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. The company reported quarterly sales of $2.03 million
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 9)
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell
• Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
Earnings Scheduled For May 17, 2021
Companies Reporting Before The Bell
• Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter.